KTOS: Record Orders, But Who Funds the Growth?

The 60-second read

Five things to know

1. Orders accelerate. Consolidated backlog reached $2.650 billion and quarterly book-to-bill was 2.2.
2. KGS leads the growth. Government solutions grew 35.8% organically; Unmanned revenue fell 14.4%.
3. Adjusted profit improved. EBITDA reached $50.9 million, while GAAP operating loss was $4.9 million.
4. Cash remains the test. Full-year company-defined free-cash-flow use is now guided at $110–120 million.
5. The valuation changed. Our prior AVOID/$26 becomes HOLD/$34 against the lower $35.10 reference close.

Three scenarios, one probability-weighted number

Author scenarios; current-dollar per-share values, not price guarantees.

Signposts: what would change our mind

Thresholds are author review rules, not company promises. Dates are research checkpoints unless explicitly attributed to management.

The price changed more than the business

Our reference is the November 6 closing price of $35.10, not an unfinished November 9 daily bar or a live quote with a different timestamp. The quote snapshot is retained separately for auditability. Kratos reported after the November 5 regular close. The next regular close rose 5.1% from the saved November 5 close of $33.39. This is a computed close-to-close response, not an attribution of every price movement to earnings. Provider change fields do not exactly match adjacent closes, so the return is calculated from the closes themselves.

The more consequential comparison is with our prior Q2 episode: AVOID, fair value $26, at a $51.87 reference price. The current reference is 32.3% lower. We now assign HOLD with a $34 base value and high uncertainty. That is a documented change of judgment, supported by stronger organic revenue, bookings and the first 2027 profit forecast. It is not a claim that the previous cash concerns disappeared, or that a lower share price alone proves value. Our new base still offers little margin of safety against the current reference.

Market capitalization is recomputed from the selected close and the 10-Q cover share count of 188,273,508 as of October 30. This deliberately avoids combining a live provider market cap with an earlier closing price. Weighted-average diluted shares belong in earnings-per-share calculations, while the cover count is the valuation starting point. Neither measure guarantees the future share count: awards, acquisition consideration and capital raising can dilute each remaining share. The point of the distinction is consistency, not artificial precision.

Growth is real; cash is still behind

Revenue of $471.8 million increased 35.7% from $347.6 million. Management reported 23.2% organic growth, which excludes the defined acquisition contribution. Adjusted EBITDA increased from $30.8 million to $50.9 million, a 65.3% increase, and its margin reached 10.8%. The GAAP operating result was a $4.9 million loss and the net result a $0.2 million loss. These are different measurements of the same quarter, not interchangeable descriptions of profitability. The reported rounded GAAP earnings per share was zero; adjusted EPS was $0.24.

The saved provider expectations are $471.398 million revenue and $0.2075 adjusted EPS. They were retrieved after the release and are not an archived pre-announcement consensus snapshot. Relative to those values, revenue is nearly in line while adjusted EPS is higher. We avoid overstating a tiny revenue difference as a decisive surprise. The more useful evidence is the company’s own prior guidance: the Q2 release had called for third-quarter revenue of $460–480 million and adjusted EBITDA of $40–45 million. The final revenue sits within that range while adjusted EBITDA exceeds its upper end.

Gross margin was 22.5%, versus 22.2% a year earlier. That modest change is less dramatic than the adjusted EBITDA increase. Growth can still create operating leverage, but the acquisition mix, amortization, company-funded development and compensation costs determine how much survives to GAAP earnings. The nine-quarter history uses primary release values rather than blindly accepting provider mappings. In particular, the provider’s Q1 2026 gross-profit and operating-income fields conflict with the actual release. The packet preserves the raw provider data and documents the corrected primary figures.

The engine is government solutions

Kratos Government Solutions supplied $397.2 million of revenue, up 52.5%, including 35.8% organic growth. Its adjusted EBITDA reached $46.3 million, compared with $24.4 million. Hypersonic and rocket work, turbine technologies, microwave products and space-related programs all matter to the investment case. The largest named growth rate was 149% for Defense Rocket Systems, but that is a business-line growth rate, not the growth rate of consolidated revenue. We do not assign an undisclosed revenue base or profit contribution to that figure.

Unmanned Systems moved in the opposite direction: revenue fell to $74.6 million from $87.2 million, a 14.4% decline. Last year included a $16.1 million international Valkyrie shipment. That comparison explains part of the decline, but does not turn the current quarter into broad drone acceleration. Segment adjusted EBITDA fell from $6.4 million to $4.6 million. Book-to-bill was only 0.8, compared with 2.5 in KGS. The company’s overall defense opportunity therefore should not be reduced to a single drone story.

Consolidated backlog rose from about $2.084 billion to $2.650 billion, up 27.2%. Approximately $2.067 billion was funded and $582.9 million unfunded. The 10-Q expects 16% of remaining performance obligations to become revenue during the rest of 2026 and another 50% during 2027. Those expectations give useful timing context, but they are neither cash receipts nor a guarantee against cancellation or schedule changes. The $15.5 billion bid pipeline is a still earlier category: opportunities being pursued, not awarded backlog.

The demand evidence is unusually strong for KGS. The key underwriting problem shifts to conversion: can contracts become delivered systems, recognized profit and collected cash without requiring disproportionately more shareholder funding? Large prime-integrator opportunities can increase revenue while reducing percentage margins because more supplier and subcontractor content passes through the company. Management explicitly discusses that possibility. A margin forecast based only on rising production volume would miss the effect of contract mix.

From adjusted EBITDA to the net loss

The reconciliation starts with the $0.2 million net loss and removes $8.7 million of net interest income, then adds tax, depreciation, stock compensation and other disclosed adjustments to reach $50.9 million of adjusted EBITDA. The largest additions include $18.1 million of stock compensation, $14.0 million of depreciation, $11.0 million of intangible amortization and $12.3 million of amortization of capitalized contract and development costs. These categories have different economic meanings. They should not all be described as one-time acquisition charges.

Interest income is a genuine economic benefit of the cash balance. It is not evidence that the operating business is self-funding. The quarterly tax expense of $4.8 million exceeds pretax income of $4.6 million; the resulting 104% effective rate is mathematically correct but not a useful normalized tax assumption. Our longer-run operating-earnings route assumes 21% tax, explicitly as an analytical input. We do not extrapolate the quarterly effective rate or apply an untaxed adjusted profit indefinitely.

The current release contains a small segment-table inconsistency: Unmanned operating loss is shown as $0.9 million and total operating loss as $4.8 million in that table. The consolidated statement and 10-Q give $4.9 million; the 10-Q segment note gives a $1.0 million Unmanned loss. We use the 10-Q GAAP values and retain management’s reported adjusted EBITDA. The difference is immaterial to valuation, but preserving the distinction prevents a false claim that every table ties exactly.

The nine recurring quality checks

Unbilled receivables of $454.3 million are about 70% of total billed and unbilled receivables. Over nine months, growth in unbilled receivables consumed $153.6 million of operating cash. Contract accounting can recognize progress before billing milestones permit collection. That is not, by itself, evidence of fictitious revenue. It does mean that rapid reported growth and positive adjusted EBITDA can coexist with a funding requirement. Contract milestones, collections and aging deserve more attention than the headline backlog alone.

The receivable and inventory day measures are deliberately simple diagnostics. They use ending balances divided by the current quarter’s revenue or cost of sales, multiplied by 91. Acquisitions and seasonality make them unsuitable as stand-alone fraud or efficiency scores. We do not publish a Beneish or Altman number without a complete, comparable input set. The useful question is whether collection improves as projects mature, while inventory bought for anticipated production is actually sold rather than left carrying capital costs.

Basic weighted shares increased 10.7% year over year. Revenue per basic weighted share therefore increased about 22.6%, below the 35.7% headline growth rate. The calculation is a shareholder-scale diagnostic, not an alternative accounting revenue figure. Dilution has financed capabilities and liquidity, so it may create value if the investments earn adequate returns. The burden of proof is that future profit and cash per share grow faster than the share count, rather than simply showing a larger company.

The cash balance was financed

Cash and equivalents reached $1.404 billion, versus $560.6 million at year-end. This is a substantial liquidity cushion. The principal financing source during the first nine months was $1.348 billion of net proceeds from common-stock issuance. Over the same interval, operating activities used $43.6 million, cash capital spending used $67.3 million, and acquisitions used $346.8 million net of acquired cash. The cash increase does not demonstrate operating cash generation. It demonstrates that investors supplied capital faster than the business deployed it.

We publish both cash definitions. Simple free cash flow subtracts capital spending from operating cash, giving a $35.4 million quarterly use. Management’s definition additionally credits asset-sale proceeds and construction grants, reducing the reported use to $29.4 million. Neither measure includes the acquisition cash cost. A reader evaluating the full capital-allocation burden should therefore inspect acquisitions separately. Grants can be economically helpful without turning the underlying operating cash line positive.

There are no drawn bank borrowings in the quarter-end balance sheet, but there are $190 million of finance-lease obligations and $56 million of operating-lease obligations. Our enterprise-value bridge subtracts finance leases from cash and leaves operating leases within operating expenses. Provider total debt includes both types, so copying it would produce a different convention. Consistency matters: capitalizing rent obligations while also charging full rent in the forecast can double count the same burden. We retain the full lease amounts so readers can choose a different, consistently adjusted model.

The company also incurred $93.6 million of noncash finance-lease obligations during the nine months. Cash capex alone therefore understates additions to committed productive assets. The base model gives credit for current net cash but does not treat the entire cash balance as a distributable special dividend. Facilities, engines, inventory, development programs and acquired operations compete for that capital. The robust balance sheet lowers near-term financing risk; it does not remove investment risk.

Three routes, one conservative center

Our three routes are intentionally different. First, a forward operating-value benchmark capitalizes the company’s 2027 adjusted EBITDA midpoint of $235 million at 25 times, adds $1.214 billion of finance-lease-adjusted net cash, and divides by 188.274 million common shares. The result is $37.65. The multiple is an author assumption, not an observed peer median or a company target. It gives considerable credit to growth while acknowledging that adjusted EBITDA omits compensation, reinvestment and several amortization categories.

Second, the cash-flow route forecasts enterprise free cash flow of negative $40 million, then $60 million, $150 million, $240 million, $330 million and $400 million during 2027–2032. These are our scenarios after operating costs, cash tax, reinvestment and working capital, not management guidance. We discount at 10%, use 3% perpetual growth after 2032, and place the first flow 1.14 years from the November 2026 valuation date. Adding the same net cash and dividing by the same shares gives $27.64. Compensation remains an economic cost in those assumed flows.

Third, the operating-earnings route assumes $3.3 billion of 2030 revenue and a 13% operating margin. Applying 21% tax produces $338.91 million of after-tax operating earnings. We apply a 25-times operating-value multiple and discount that enterprise value 4.14 years at 10%, then add current net cash. This gives $36.78 per share. Because this is an enterprise-value proxy using after-tax operating earnings, it is not a conventional price-to-earnings calculation. Interest income is excluded, preventing the cash balance from being counted both as an asset and as capitalized interest earnings.

The equal-weight center is $34.02, rounded to a $34 published base. Our bear, base and bull values are $20, $34 and $52 with probabilities of 25%, 50% and 25%, giving a $35 probability-weighted value. Scenario endpoints are author judgments informed by growth, margin, dilution and funding risk; they are not statistical confidence limits. The base value and weighted value answer different questions, so both remain visible. High uncertainty leads us to seek a 25% discount to base, or $25.50, before considering a new purchase, and only if the operating thesis remains intact.

At the selected price, computed enterprise value is $5.394 billion, or about 23.0 times the 2027 adjusted EBITDA midpoint. Holding the first five cash-flow amounts and other DCF assumptions fixed, a reverse calculation requires approximately $560.5 million of 2032 cash flow to support the quoted value, versus our $400 million assumption. The solved amount replaces both the explicit sixth-year cash flow and the base for terminal growth. This is a narrow sensitivity, not a complete market forecast. It shows how heavily value depends on eventual cash conversion. A different discount rate, dilution path or terminal growth rate changes the answer materially.

Fresh targets and stale averages

The freshest saved target is Jefferies at $50 on November 9, after the release. Piper Sandler’s October 23 $61 target and Oppenheimer’s October 22 $50 target predate this print. The provider consensus target is $87.53, with a $50–135 range, while the ratings distribution contains one strong buy, twenty-one buys and three holds. That aggregate is much more optimistic than our $34 base, but its freshness is uneven. We do not label every contributing target a post-earnings reassessment.

Our difference with the Street is not a denial of demand. It is a lower willingness to capitalize future adjusted earnings before collection, reinvestment and share-count effects are established. The saved annual estimates extend beyond management’s initial 2027 outlook and contain varying analyst counts. They provide context, not evidence that a distant forecast is probable. We neither substitute consensus for a valuation nor invent an undisclosed firm rating from a price target alone. The episode names the firm and date so the viewer can judge the comparison.

Grade the previous call honestly

Our previous episode asked for two consecutive quarters of positive free cash flow after capex, adjusted EBITDA margin above 11%, or a 2027 outlook with capex declining in dollars. None of those positive conditions is fully demonstrated here. Third-quarter company-defined free cash flow remains negative, the adjusted EBITDA margin is 10.8%, and 2027 cash-flow guidance will not be supplied until the fourth-quarter report. The prior warning about full-year cash use worse than $105 million has triggered: management now expects $110–120 million of use.

Why move to HOLD despite those warnings? KGS organic growth, the order intake and the 2027 revenue and EBITDA forecasts improve the future operating case, while the reference share price is much lower. The revised rating balances those improvements against cash evidence that is still weak. It is not a retrospective claim that every original signpost passed. A disciplined process can change its fair value and rating while acknowledging which predictions were right and which new facts altered the judgment.

Capital allocation deserves a mixed assessment. The equity raises provide resources for a demanding industrial expansion and reduce reliance on borrowing. Acquisitions broaden capabilities: Orbit closed on March 2 for approximately $352.7 million in cash, and Nomad closed February 11 using stock, cash and contingent arrangements. These are completed transactions, not eligibility exclusions. Their future returns, integration costs and amortization burden remain analytical questions. Acquisition accounting and operating progress should be reviewed together instead of treating all purchased growth as organic execution.

1. When will unbilled receivables convert to invoices and cash, by major program?
2. How much 2027 investment is already contract-funded versus committed ahead of awards?
3. What delivery and collection assumptions bridge engine production capacity to customer sales?
4. What share-count growth is assumed in management’s long-range value expectations?
5. Which large opportunities could dilute margins through subcontractor content, and how are returns protected?

The best bull and bear arguments

The strongest bull case is that Kratos has already built specialized capabilities that customers increasingly need, and the backlog now validates that investment. Production scale can improve fixed-cost absorption, and the cash balance allows management to fund facilities and long-lead materials without an immediate liquidity squeeze. If the initial 2027 forecast proves conservative and working capital unwinds as milestones are achieved, our $34 base could understate the business. The $52 bull scenario requires sustained growth, better cash conversion and continued operating leverage, rather than simply a higher market multiple.

The strongest bear case is that growth continually demands new inventory, facilities and development spending while adjusted earnings exclude real shareholder costs. Large programs can shift timing, use substantial subcontractor content and generate weak percentage margins. Unmanned’s quarterly order intake is below revenue, and the cash-use outlook has deteriorated. More capital may eventually be required even with a healthy starting balance. The $20 bear scenario reflects slower conversion, lower profitability and valuation compression; it does not require the defense opportunity to disappear.

Government funding is especially important to timing. The release assumes a continuing resolution into early 2027 and states that an extension beyond March 31 would require reassessing the initial forecast. It also does not assume a federal shutdown. We report those as management’s dated assumptions, not an independent prediction of legislation. The annual growth outlook is weighted toward the second half. A weak first quarter therefore may be consistent with the plan, whereas a later budget delay could undermine the plan itself.

Check delivery, not just announcements

The next full-year report is expected by management in late February 2027. It should include the missing 2027 operating and free-cash-flow guidance. Our February 28 review date is a research checkpoint, not a confirmed earnings appointment. The December 11 continuing-resolution reference and March 31 reassessment threshold come from the November 5 release. They should be revisited against subsequent official developments before any future episode narrates them as current facts.

Management expects production of up to 3,000 turbojet engines in 2027 but forecasts sales to customers of approximately 1,500, mostly in the second half. Those are different quantities. Calling all planned production sold would overstate demand conversion and understate inventory funding. The pipeline also includes internally funded facilities, capital drones and development initiatives. Track completed deliveries and collection milestones alongside manufacturing capacity, because investors ultimately own the cash remaining after that production system is funded.

Data, definitions and source trail

Amounts are U.S. dollars unless stated otherwise. Historical tables use each period’s primary release for consolidated and segment headline results; the current GAAP segment discrepancy is resolved to the 10-Q. The provider’s December 31, 2024 fiscal-year-end label is aligned to the issuer’s December 29 year-end for matching, with the original provider record retained. No new quarter is invented by that mapping. Historical segment comparatives may differ by small rounding or classification amounts across release vintages. Raw tables, provider snapshots and calculations are retained in the episode dataset.

Kratos is a U.S. common-stock issuer listed on Nasdaq, not an ADS or variable-interest-entity investment structure. Deloitte & Touche LLP audited the 2025 financial statements and internal controls. The annual report states that the company has not declared cash dividends since becoming public and does not expect dividends or stock buybacks in the foreseeable future. Employee counts include full-time, part-time and on-call staff; they are not full-time-equivalent productivity denominators. The current 10-Q reports effective disclosure controls and ongoing acquisition integration work.

Adjusted EBITDA and adjusted EPS are company-defined non-GAAP measures. Simple free cash flow in this packet means operating cash less cash capex. Company-defined free cash flow additionally credits asset-sale and state-grant proceeds. Backlog describes awarded remaining performance obligations; funded backlog, unfunded backlog and bid pipeline are distinct categories. Organic growth follows the issuer’s acquisition-exclusion definition. None of those labels overrides the GAAP statements. Valuation inputs, probabilities and review thresholds are Charged Alpha assumptions, and computed figures are generated in the accompanying calculation file.

• 2024-09-29 earnings release and reconciliation
• 2024-12-29 earnings release and reconciliation
• 2025-03-30 earnings release and reconciliation
• 2025-06-29 earnings release and reconciliation
• 2025-09-28 earnings release and reconciliation
• 2025-12-28 earnings release and reconciliation
• 2026-03-29 earnings release and reconciliation
• 2026-06-28 earnings release and reconciliation
• 2026-09-27 earnings release and reconciliation
• 2025 annual report
• 2024 annual report
• 2023 annual report
• Q3 2026 10-Q
• Issuer release, November 5, 2026
• FMP saved financial, quote, price, analyst and earnings datasets retrieved November 9, 2026

The research has limits. An issuer source establishes what management reported, not certainty that its forecasts will occur. Analyst data retrieved after the print cannot reconstruct a clean pre-release consensus without an archived snapshot. Our scenarios do not model every contract, and the cash-flow route is particularly sensitive to terminal cash generation. The small source discrepancies are disclosed because an auditable model is more useful than a false appearance of perfect agreement. Future packets should grade the dated signposts and preserve this call alongside the result.